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Summary
 
Scrape loading 
 
Clostridium botulinum
 
 C3 exoenzyme into primary peripheral blood human T
lymphocytes (PB T cells) efficiently adenosine diphosphate (ADP)-ribosylates and thus inacti-
 
vates the guanosine triphosphatase (GTPase) Rho. Basal adhesion of PB T cells to the 
 
b
 
1 inte-
grin substrate fibronectin (Fn) was not inhibited by inactivation of Rho, nor was upregulation
 
of adhesion using phorbol myristate acetate (PMA; 10 ng/ml) or Mn
 
11
 
 (1 mM) affected.
Whereas untreated PB T cells adherent to Fn remain spherical, C3-treated PB T cells extend
F-actin–containing pseudopodia. Inactivation of Rho delayed the kinetics of PMA-dependent
PB T cell homotypic aggregation, a process involving integrin 
 
a
 
L
 
b
 
2. Although C3 treatment
of PB T cells did not prevent adhesion to the 
 
b
 
1 integrin substrate Fn, it did inhibit 
 
b
 
1 inte-
grin/CD3-mediated costimulation of proliferation. Analysis of intracellular cytokine produc-
tion at the single cell level demonstrated that ADP-ribosylation of Rho inhibited 
 
b
 
1 integrin/
CD3 and CD28/CD3 costimulation of IL-2 production within 6 h of activation. Strikingly,
IL-2 production induced by PMA and ionomycin was unaffected by C3 treatment. Thus, the
GTPase Rho is a novel regulator of T lymphocyte cytoarchitecture, and functional Rho is re-
quired for very early events regulating costimulation of IL-2 production in PB T cells.
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T
 
he actin cytoskeleton is clearly important in the regu-
lation of T lymphocyte activity at a variety of different
levels. A number of cell surface proteins involved in T cell
function are associated with cytoskeletal complexes, in-
cluding integrin receptors of the 
 
b
 
1 and 
 
b
 
2 subfamilies (1),
CD45 (2, 3), CD2, CD4, CD8, CD44, class I MHC (4),
and the 
 
z
 
 chain of the TCR–CD3 complex (5–7). As such,
an intact cytoskeleton is essential for sustained signals re-
quired for T cell activation and may be necessary for TCR
aggregation (8), as well as the spatial redistribution of cell
surface molecules at the contact site between antigen-pre-
senting cells and T cells (9). The role of the actin cytoskel-
eton is emerging as not just a conglomeration of protein
subunits maintaining cell shape, but rather, as a highly co-
ordinated molecular array providing a scaffold for the spa-
tial distribution of mechanistic and signaling components
requisite for physiologic function of T lymphocytes.
Key regulators of the actin cytoskeleton involve small
GTPases of the Rho family. These include RhoA, RhoB,
RhoC, RhoD, RhoE, Cdc42, TC10, G25K, Rac1, and
Rac2 (for review see references 10, 11). Rho proteins are
biochemical switches that when in the GTP-bound state
 
regulate diverse biological phenomenon ranging from mor-
phological changes to cytokinesis and gene induction. C3
exoenzyme from 
 
Clostridium botulinum
 
 specifically inhibits
Rho activity, and not that of Rac or Cdc42 proteins, by
adenosine diphosphate (ADP)
 
1
 
-ribosylating Rho on Asn
 
41
 
(12) of the Rho effector domain. By using this Rho-spe-
cific inactivator, it has been demonstrated in leukocytes
that Rho activity is required for B cell homotypic aggrega-
tion (13) and chemokine-induced adhesion (14), neutro-
phil migration and upregulated adhesion (14–16), NK cell
mobility and cytolytic activity (17, 18), and the mainte-
nance of monocyte morphology (19, 20). Recently, thy-
mus-targeted C3 transgenic mice have been developed that
demonstrate markedly decreased thymic mass and de-
creased numbers of mature T cells (21). In contrast, no
studies to date have addressed the function of Rho in regu-
lation of human peripheral blood T lymphocyte (PB T cell)
 
1
 
Abbreviations used in this paper:
 
 4,5-PIP
 
2
 
, phosphatidylinositol 4,5-bisphos-
phate; ADP, adenosine diphosphate; Fn, fibronectin; GTP, guanosine
triphosphatase; PB, peripheral blood; PIP 5-kinase, phosphatidylinositol
4-phosphate 5-kinase; PLC, phospholipase C.
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activation or in the regulation of the actin cytoskeleton.
We have used the Rho-specific inactivator, C3 exoenzyme
(12), to demonstrate the requirement of functional Rho in
homotypic aggregation, maintenance of cell shape, and fi-
nally, in the costimulation of proliferation and IL-2 pro-
duction in primary PB T cells.
 
Materials and Methods
 
Reagents.
 
PMA, ionomycin, poly-
 
L
 
-lysine, and TRITC-
phalloidin were purchased from Sigma Chemical Co. (St. Louis,
MO). Fibronectin (Fn) was affinity purified from 200 ml of hu-
man plasma (Gulf Coast Regional Blood Center, Houston, TX)
according to Hynes (22). Fn purity was determined by SDS-
PAGE. Ig from the anti-CD3 mAb OKT3 hybridoma was puri-
fied from ascites. Anti-
 
b
 
1 integrin mAb 33B6 and anti-
 
a
 
4
 
b
 
1 in-
tegrin mAb 19H8 were generated in this laboratory and have
been previously described (23, 24). The anti-
 
a
 
L
 
b
 
2 mAb 85G1
was generated in this laboratory. mAbs rat anti–human IL-2–PE
(IgG2a), anti–CD4-Cychrome (IgG1), control rat IgG2a-PE, and
control IgG1-Cychrome were all purchased from PharMingen
(San Diego, CA). Anti-CD28 mAb Leu28 and anti-
 
ab
 
-TCR
mAb were purchased from Becton Dickinson Immunocytometry
Systems (San Jose, CA).
 
Cells.
 
The T cell line J45.01 (American Type Culture Col-
lection, Rockville, MD) was maintained in complete media
(RPMI-1640 supplemented with 10% FBS, 10 U/ml of both
penicillin and streptomycin; and 1 mM 
 
L
 
-glutamine; all from
GIBCO BRL, Gaithersburg, MD). Purified T cells were ob-
tained by negative selection as previously described (25). In brief,
mononuclear cells were isolated from the buffy coats (Gulf Coast
Regional Blood Center) of healthy donors by density-dependent
cell separation on Ficoll-Hypaque (1.077 g/ml; Amersham Phar-
macia Biotechnology Inc., Piscataway, NJ). Monocytes were re-
moved by several rounds of plastic adherence on tissue culture–
treated petri dishes (Corning Glass Works, Corning, NY) for 45
min at 37
 
8
 
C and 5% CO
 
2
 
. Further density dependent cell separa-
tion was performed on discontinuous percoll (295 mOsm; Sigma
Chemical Co.) gradients (44, 48, and 60% vol/vol percoll in
RPMI-1640; GIBCO BRL) to remove residual monocytes,
PMNs, and red blood cells. The 48%/60% interface layer was
carefully collected, washed in RPMI-1640, and then B lympho-
cytes were removed by adherence to nylon wool (Polysciences
Inc., Warrington, PA) columns for 45 min at 37
 
8
 
C and 5% CO
 
2
 
.
The resultant lymphocyte population was routinely 
 
.
 
95% CD3
 
1
 
as determined by flow cytometric analysis (Epics Profile; Coulter
Immunology, Hialeah, FL). Purified T cells were maintained in
complete media and used within 24 h of isolation.
 
Western Blotting.
 
Cell lysates from 
 
z
 
2
 
 3 
 
10
 
6
 
 cell equivalents
(J45.01) or 3
 
 3 
 
10
 
6
 
 cell equivalents (PB T cells) were subjected to
12.5% SDS-PAGE and transferred to polyvinylidene difluoride
(PVDF) membranes (Bio-Rad Laboratories, Hercules, CA). The
following Western blotting steps were carried out at 4
 
8
 
C for at
least 2 h. PVDF membranes were blocked with 5% BSA and 5%
nonfat milk in TBS/Tween (10 mM Tris-HCl, pH 8.0, 150 mM
NaCl, and 0.05% Tween-20) after transfer from gels. Membranes
were extensively washed and then incubated with the primary
(0.5 
 
m
 
g/ml) goat anti–RhoA polyclonal antibody (Santa Cruz
Biotechnology, Santa Cruz, CA). After washing, membranes
were incubated with goat anti–rabbit HRP (Cappel Laboratories,
Malvern, PA). Chemiluminescence was performed as described
by the manufacturer (Pierce Chemical Co., Rockford, IL).
 
Cell Adhesion Assays.
 
Adhesion assays were performed in
modified Tyrodes buffer (26) composed of 12 mM NaHCO
 
3
 
, pH
7.4, 150 mM NaCl, 2.5 mM KCl, 2 mM MgCl
 
2
 
, 1 mg/ml BSA,
and 1 mg/ml glucose. Plates were precoated with Fn (10 
 
m
 
g/ml)
for at least 2 h at room temperature in 0.1 M NaHCO
 
3
 
. BSA (2%
wt/vol) was then added to block unbound sites. Cells were resus-
pended in modified Tyrodes buffer alone or in modified Tyrodes
buffer containing PMA (10 ng/ml) or Mn
 
11
 
 (1 mM). After 1 
 
3
 
10
 
5
 
 cells were added to the washed plates in 100 
 
m
 
l of modified
Tyrodes, plates were spun at 300 rpm for 5 min and then incu-
bated for 45 min at 37
 
8
 
C and 5% CO
 
2
 
. Two digitized images
captured as described in Szabo et al. (27) were analyzed using
National Institutes of Health Image software (available from ftp:
//codon.nih.gov/pub/nih-image/nih-image161_fat.hqx) from each
well before washing and then plates were carefully washed 4
 
3
 
with prewarmed (37
 
8
 
C) modified Tyrodes buffer. After washing,
images from the prewash position were analyzed again. Cell
numbers were quantitated using NIH Image software and adhe-
sion assays are graphed as the percentage of input cells remaining
after washing.
 
Quantitation of Cell Morphology.
 
Quantitation of cell mor-
phology by digital image analysis was performed as described pre-
viously (27). Images of Fn adherent cells (obtained from the same
cells used in the adhesion assays described above) were digitized
and analyzed with NIH Image software. Dividing the theoretical
maximum area for a given perimeter (perimeter
 
2
 
/4
 
p
 
) by the ob-
served area provides a spreading index where absolute roundness
is 1.0 (27). Any deviation from roundness gives a spreading index
 
.
 
1.0. Random fields of adherent cells were captured from vari-
ous treatment groups and the spreading index quantitated. A per-
cent change from roundness was calculated according to the fol-
lowing formula: % change 
 
5 
 
([morphological index C3 treated
 
2
 
 1.0]/[morphological index C3 control 
 
2
 
 1.0]) 
 
3
 
 100.
 
Intracellular Incorporation of Macromolecules into Freshly Isolated PB
T Lymphocytes.
 
C3 was scrape loaded into freshly isolated PB T
lymphocytes. Bacteriological petri dishes (35 mm; Becton Dick-
inson Labware (Lincoln Park, NJ) were coated with the nonspe-
cific cell attachment factor poly-
 
L
 
-lysine (10 
 
m
 
g/ml) in PBS for at
least 2 h at room temperature and then blocked with 1% (wt/vol)
BSA for 30 min at room temperature. Cells were washed 4
 
3
 
 in
RPMI-1640 and resuspended at 10 
 
3
 
 10
 
6
 
 cells/ml in RPMI-
1640. These cells were plated (
 
,
 
15 
 
3
 
 10
 
6
 
 cells/dish) onto PBS
washed poly-
 
L
 
-lysine dishes and incubated for 30 min at 37
 
8
 
C.
After incubation, supernatants were removed and at least 200 
 
m
 
l
of prewarmed (37
 
8
 
C) RPMI-1640 containing C3 (50 
 
m
 
g/ml) or
appropriate controls were gently layered over the cells. After fur-
ther incubation for 5 min at 37
 
8
 
C, cells were physically removed
from the surface with a cell scraper (Costar, Cambridge, MA).
These cells were then collected and placed in a 37
 
8
 
C 5% CO
 
2
 
 hu-
midified incubator for at least 1 h before use. Cells treated under
the scrape loading conditions maintain functionality and sufficient
quantities can be recovered for biochemical analysis (28).
 
C3 Purification.
 
C3 purification has been described in detail
elsewhere (29). In brief, JM109 transformed with C3 plasmid
pGEX2T-C3 (provided by Dr. L. Feig, Tufts University, Boston,
MA) were incubated with isopropyl-
 
b
 
-
 
D
 
-thiogalactopyranoside
(100 
 
m
 
g/ml) during exponential growth phase for 4 h. Bacteria
were lysed in cold PBS containing 1 mg/ml lysozyme, 1% Triton
X-100, 25% sucrose, 1 mM EDTA, 5 mM 2-mercaptoethanol,
and 1 mM PMSF. After sonication and DNase I (100 
 
m
 
g/ml;
Boehringer Mannheim Corp., Indianapolis, IN) treatment, the
lysate was centrifuged and supernatant was added to glutathione-
agarose beads (Amersham Pharmacia Biotechnology Inc.), which 
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were rotated overnight at 4
 
8
 
C. C3 was cleaved from washed
beads with 30 NIH units of bovine 
 
a
 
-thrombin (Sigma Chemical
Co.) and concentrated using a Centricon-3 (Amicon Corp., Eas-
ton, TX). The purity of C3 preparations was determined by
SDS-PAGE. Control buffer for scrape loading of C3 consisted of
the buffers used here, including the appropriate concentration of
bovine 
 
a
 
-thrombin used in the purification of C3.
 
C3 Ribosylation.
 
C3 was scrape loaded into PB T lympho-
cytes at a concentration of 50 
 
m
 
g/ml. After scrape loading, cells
were transferred into 1.5-ml eppendorf tubes and incubated for 1 h
at 37
 
8
 
C to allow ribosylation. Cells were then washed extensively
in 1% BSA/PBS to remove any C3 not incorporated into the
cells. Next, the cells were resuspended at 5 
 
3
 
 10
 
6
 
 cells/ml in ice-
cold sonication buffer (250 mM sucrose, 10 mM Hepes, pH 7.4,
1 mM EDTA, 5 mM MgCl
 
2
 
, 1 mM dithiothreitol [DTT], 0.1
mM GTP, 1 
 
m
 
g/ml leupeptin, 1 
 
m
 
g/ml pepstatin A, 1 
 
m
 
g/ml
aprotinin, and 1 mM PMSF) and sonicated for 10 s. After sonica-
tion, 100 
 
m
 
l of the mixture was added to 50 
 
m
 
l of 3
 
3
 
 reaction
buffer containing 150 mM Tris-HCl, pH 8.0, 30 mM thymidine,
3 mM DTT, 5 mM MgCl
 
2
 
, and 0.3 mM GTP. To this mixture,
1.0 
 
m
 
g purified C3 and 2 
 
m
 
Ci 
 
32
 
[P]-NAD (Dupont-NEN, Bos-
ton, MA) were added. After incubation for 1 h at 37
 
8
 
C, SDS was
added to 2% final wt/vol and this mixture was immersed in a
boiling water bath for 10 min. Eight volumes of ice-cold ethanol
was then added and these samples were kept at 
 
2
 
20
 
8
 
C for at least
1 h. Precipitated proteins were pelleted and dissolved in SDS-
PAGE sample buffer by boiling for 10 min. Samples were then
subjected to 12.5% SDS-PAGE and analyzed by autoradiography.
 
T Cell Costimulation of Proliferation.
 
Immobilization of mAb
to Easy Wash Elisa plates (Corning Glass Works) was performed
by first incubating 50 
 
m
 
l (1 
 
m
 
g/ml in 0.1 M NaHCO
 
3
 
, pH 8.0) of
anti-CD3 mAb OKT3 for at least 30 min at room temperature
before the addition of 50 
 
m
 
l of anti-
 
b
 
1 integrin mAb 33B6 or
anti-
 
a4b1 integrin mAb 19H8 (both at 8 mg/ml). After at least 2 h
at 378C, plates were blocked with BSA (1%, wt/vol). Plates were
washed extensively before use with RPMI-1640. Purified human
peripheral blood T cells that had been scrape loaded with BSA
(50 mg/ml)/buffer control or with C3 exoenzyme (50 mg/ml)
were then plated (5 3 104 cells/well) onto the immobilized co-
stimulatory mAb in complete media. Approximately 2–3 d after
initial plating, cells were pulsed with 0.5 mCi 3[H]thymidine
(Amersham Pharmacia Biotech Inc., Piscataway, NJ) in 50 ml
complete media. After a 24-h incubation period, cells were har-
vested onto glass fiber filter mats (Whatman Ltd, Maidston, UK)
using a PHD cell harvester (Cambridge Technology Inc., Cam-
bridge, MA). 3[H]Thymidine incorporation was measured via
standard liquid scintillation counting (Beckman LS2800; Beck-
man Instruments Inc., Fullerton, CA).
Single Cell Analysis of Intracellular Cytokine Accumulation and ab-
TCR Downregulation. PB T cells were plated in complete media
supplemented with 4 mM monensin (Sigma Chemical Co.) in
12-well tissue culture plates for activation by PMA (10 ng/ml)
and ionomycin (1 mg/ml), or in bacteriological petri dishes that
had been precoated with Fn, anti-a4b1 mAb 19H8, anti-b1
mAb 33B6, or anti-CD28 mAb Leu28 (10 mg/ml in 0.1 M
NaHCO3, pH 8.0), all in conjunction with the anti-CD3 mAb
OKT3 (1 mg/ml in 0.1 M NaHCO3). After 6 h, cells were har-
vested and intracellular cytokine production was measured. For
the measurement of ab-TCR downregulation, monensin was
omitted from the culture medium. In brief, cells were washed
once in stain/wash buffer (1% FBS and 0.1% NaN3 in PBS). Di-
rectly conjugated antibodies to CD4 (see Figs. 6 and 7) or the
ab-TCR (see Fig. 8) were added, incubated for 30 min at 48C,
then washed in stain/wash buffer. Cells were fixed in 2% (wt/vol)
paraformaldehyde overnight at 48C, then permeabilized by wash-
ing once and resuspending with 0.1% (wt/vol) saponin (Sigma
Chemical Co.), 1% FBS, and 0.1% NaN3 in PBS (permeabiliza-
tion buffer). Directly conjugated anti–IL-2 mAb was then added.
After 30 min at 48C, cells were again washed in permeabilization
buffer two times, once in stain/wash buffer, and then read on an
Epics Profile flow cytometer (Coulter Immunology). Control
staining was performed with directly conjugated isotype and fluo-
rochrome-matched immunoglobulin and then a minimum of 2 3
104 events were counted per test sample.
F-Actin Staining. PB T cells that had been scrape loaded with
BSA (50 mg/ml) or C3 (50 mg/ml) were incubated in modified
Tyrodes buffer on glass coverslips that had been precoated with
Fn (10 mg/ml, in Tris-HCl, pH 9.5). Adherent PB T cells were
then fixed overnight at 48C in 2% paraformaldehyde. After fixa-
tion, cells were then treated with 0.1% Triton X-100 in PBS for
1 h at 48C. Cells were then washed and incubated with 0.8 mM
TRITC-phalloidin for 2 h at 48C in PBS containing 1% FBS. Af-
ter washing, coverslips were air dried and mounted in n-propyl
gallate (2% wt/vol) in glycerol containing 10% PBS and then vi-
sualized on a Nikon Diaphot TMD inverted microscope.
Results and Discussion
C3 Induces ADP-Ribosylation of Rho in Human PB T
Cells. Western blotting analysis confirmed the presence of
RhoA (z25 kD) in the Jurkat variant J45.01 and PB T
cells (Fig. 1 A). To study the role played by Rho in PB T
cells we developed a technique allowing intracellular incor-
poration of macromolecules into freshly isolated T cells
that maintains their functional cellular integrity and allows
recovery of quantities of cells sufficient for biochemical
analyses (28). This technique involves scrape loading T cells
that are firmly adherent to the nonspecific cell attachment
factor poly-L-lysine. After scrape loading BSA (50 mg/ml)
as a control or C3 exoenzyme (50 mg/ml), cells were incu-
Figure 1. (A) Western blot of RhoA protein in whole cell lysates of
the T cell line J45.01 and purified PB T lymphocytes. (B) Scrape loading
efficiently incorporates enough C3 into freshly isolated, highly purified
PB T lymphocytes for full ribosylation of Rho. Purified resting PB T cells
were untreated (lane 1), scrape loaded with 50 mg/ml BSA and control
buffer (lane 2), non-scrape loaded but incubated in the presence of C3 (50
mg/ml, lane 3), or scrape loaded in the presence of C3 (50 mg/ml, lane
4). See Materials and Methods for ribosylation reaction. Equal cell equiv-
alents were loaded per lane. One of two representative experiments is
shown.1214 Rho-dependent Regulation of PB T Lymphocyte Cytoarchitecture and Activation
bated for 1 h at 378C to allow in vivo ribosylation. Cells
were then washed thoroughly, sonicated, and lysates sub-
jected to further C3 ribosylation by the addition of 2 mCi
32[P]-NAD and 1 mg of C3 in ribosylation buffer. If full ri-
bosylation of Rho proteins occurred before cell lysis due to
effective C3 incorporation, then Rho would not be further
ADP-ribosylated using 32[P]-NAD as the ADP-donor (30).
As Fig. 1 B demonstrates, scrape loading was a very effec-
tive procedure for incorporating C3 into PB T cells. Cells
that were scrape loaded with BSA control (Fig. 1 B, lane
2), or cells that were not plated on poly-l-lysine but incu-
bated in the presence of C3 (Fig. 1 B, lane 3), both could
be further ribosylated by C3 in vitro after cell lysis. How-
ever, scrape loading of C3 (50 mg/ml) and thus causing in
vivo ribosylation before cell lysis was very efficient as no
further in vitro ribosylation of Rho occurred after cell dis-
ruption (Fig. 1 B, lane 4).
Rho Differentially Regulates b1 and b2 Integrin-dependent
Adhesive Interactions in PB T Lymphocytes. Freshly isolated
resting PB T cells generally demonstrate low adhesion to
b1 integrin substrates such as the extracellular matrix com-
ponent Fn (31). However, adhesion can be augmented by
various agents that seem to act by distinct methods. PMA
can increase integrin-dependent cellular interactions not
necessarily by increasing integrin affinity, but by events that
strengthen intracellular integrin–cytoskeletal contacts and,
thus, increase overall cellular avidity (26). Mn11, on the
other hand, binds to divalent cation binding sites in the ex-
tracellular regions of integrins and causes a conformational
change into a high affinity form also resulting in increased
cellular adhesion (32). As demonstrated in Fig. 2 A, basal
adhesion of PB T cells to Fn was ,10%, and this was de-
pendent on a4b1 and a5b1 integrins (data not shown).
Baseline adhesion was not inhibited by the ADP-ribosyla-
tion of Rho in C3 scrape-loaded cells (Fig. 2 A). Upregula-
tion of PB T cell adhesion to Fn induced by PMA (10 ng/ml)
or Mn11 (1 mM) was also unaffected by C3 treatment
(Fig. 2 A). Like basal adhesion, PMA-induced adhesion
was maximally inhibited with a combination of mAb spe-
cific for integrins a4b1 and a5b1, for both BSA scrape-
loaded control cells and C3 scrape-loaded cells (Fig. 2 B).
In summary, active Rho is not required for baseline or up-
regulated PB T cell adhesion to Fn mediated by phorbol
ester or Mn11.
Previous studies have shown that phorbol ester induc-
tion of B lymphoblastoid adhesion to vascular cell adhesion
molecule 1 (mediated through a4 integrins; reference 33)
can be inhibited in a dose-dependent manner by C3 exo-
enzyme (14), and NIH 3T3 cells microinjected with C3
detach from b1 integrin substrate (34). Conversely, inacti-
vation of Rho in monocytes can promote integrin a5b1-
dependent adhesion to Fn (35). In fact, elongation of the
neuronal cell growth cone (38) and extension of dendritic
like pseudopodial processes in T cell lines plated on b1 in-
tegrin substrates occurs upon inactivation of Rho (data not
shown). According to models of cellular motility, pseudo-
pod extension requires de novo formation of adhesive sites
(36, 37), implying that in neuronal cells and PB T cells, in-
activation of Rho does not prevent the formation of adhe-
sive contacts. Thus it appears that Rho regulation of inte-
grin adhesion is unique to the cellular background within
which Rho is studied.
Although inactivation of Rho in PB T cells does not af-
fect adhesion to the b1 integrin substrate Fn as regulated by
PMA or Mn11, it does inhibit PMA-dependent homo-
typic aggregation (Fig. 3). Treatment of resting PB T cells
with PMA induces the formation of cellular aggregates, as
seen in the BSA scrape-loaded control cells (Fig. 3 C),
whereas scrape loading C3 exoenzyme into PB T cells in-
hibits the formation of large aggregates (Fig. 3 D). This is
similar to previous reports in B cell lines, where treatment
with C3 inhibits PMA-induced aLb2/intracellular adhe-
sion molecule (ICAM)–dependent homotypic aggregation
(13). C3-treated PB T cells still have the ability to aggre-
gate, as an activating antibody specific for integrin aL,
mAb 85G1, can overcome the inhibitory effects of C3 and
induce aggregate formation (data not shown). Also, as ag-
gregation progresses over 18–24 h, PMA-induced aggrega-
tion of the C3-treated cells approximates that of control
BSA scrape-loaded cells (data not shown). This suggests
Figure 2. (A) ADP-ribosylation of Rho in PB T cells does not alter ad-
hesion to Fn. An adhesion assay using untreated PB T cells, PB T cells
scrape loaded with BSA (50 mg/ml) 1 control buffer, and C3 (50 mg/ml)
scrape-loaded PB T cells, was performed. PMA (10 ng/ml) or Mn11 (1
mM) were added at the beginning of the assay to upregulate adhesion to
Fn. One out of four representative experiments is shown. (B) Adhesion to
Fn was tested in the presence of various mAb (10 mg/ml) to integrin sub-
units. Open bars represent BSA (50 mg/ml) scrape-loaded control cells.
Stippled bars represent C3 exoenzyme (50 mg/ml) scrape-loaded test cells.
Bars represent quadruplicate determinations and are expressed as the aver-
age 6 SEM. One out of three representative experiments is shown.1215 Woodside et al.
that the kinetics of PMA-induced aggregation are slower in
the presence of C3. PMA-induced homotypic aggrega-
tion is a dynamic process, which in PB T cells predomi-
nantly involves integrin aLb2/ICAM interactions (data not
shown). In contrast, PB T cell adhesion to Fn can be medi-
ated by a4b1 interaction with the alternatively spliced con-
necting segment-1 sequence EILDV (39) and/or via the
canonical Fn receptor a5b1 interaction with RGD se-
quences (40). If b2 integrin–dependent homotypic aggre-
gation can be equated with b1 integrin–dependent adhe-
sion to Fn, then the above results suggest that Rho may
differentially regulate b2 and b1 integrins within PB T
cells. It will be interesting to determine if Rho plays a role
in the complex pathways regulating a variety of recently de-
scribed integrin related phenomena, such as transdominant
regulation of integrin activity, whereby engagement of one
integrin can regulate the function of other heterologous
integrins (25, 41–45), or in the sequential solicitation of in-
tegrin a4b1 and a5b1 in monocyte adhesion to Fn induced
by the CC chemokines MIP1-a or RANTES (46).
ADP-ribosylation of Rho in PB T Cells Causes F-Actin–rich
Pseudopodial Extension on Fn Adherent Cells Without Any Prior
Cellular Activation. Although the inhibition of Rho activ-
ity by C3 exoenzyme did not prevent constitutive or up-
regulated cell adhesion to the matrix component Fn, what
was striking was the profound influence that scrape loading
C3 exoenzyme had on the morphology of Fn adherent PB
T cells. Adherent resting PB T cells generally remain round
(Fig. 4 A, left). By scrape loading C3 alone, pseudopodial
extension occurs without any prior T cell stimulation (Fig.
4 A, right). This morphological change occurred within 1 h
of T cell plating and is quantitated in Fig. 4 B. Fn adherent
C3-treated cells on average have a morphological index of
2.01 6 0.08, whereas Fn adherent control PB T cells have
a morphological index of 1.39 6 0.04 (Fig. 4 B). This rep-
resents a 259.0% change from roundness (see Materials and
Methods for formula) in the C3-treated cells. Aberrant
pseudopodial extension continued well past the 1-h time
point documented in Fig. 4, A and B, and extensions dras-
tically elongated over time. In some instances, after 4 h
these altered pseudopods were approximately nine times
the width of a single cell (Fig. 4 C).
The extended pseudopods of the C3-treated PB T cells
contained filamentous actin, some of which was in small
punctate clusters (Fig. 4 D, arrows), which may represent
coalescing actin cables such as those recently described in
Figure 3. Inactivation of Rho inhibits PMA induced PB T cell homo-
typic aggregation. Cells were scrape loaded with BSA/buffer control (50
mg/ml, A and C), or C3 (50 mg/ml, B and D) as described in the Materi-
als and Methods. Cells were not treated (A and B) or PMA treated (10
ng/ml, C and D) and then incubated for 4 h at 378C. Initial magnification
was 1003. One of three representative experiments is shown.
Figure 4. C3 ADP-ribosylated PB T cells extend pseudopodia when
adherent to Fn. (A) Under similar conditions of the cell adhesion assays
(see Materials and Methods), images of Fn adherent cells that had been
scrape loaded with BSA (50 mg/ml) and buffer controls (scrape loading
control) or cells that had been scrape loaded with C3 (50 mg/ml) were
obtained. One of three representative experiments is shown. (B) Images
were collected to quantitate (see Materials and Methods) the spreading in-
dex for control and C3-treated Fn adherent PB T lymphocytes. (C) An
example of a cell that continued to elongate after a 4-h time period. Pro-
jections were up to nine times (in length) the width of a single cell. (D)
Filamentous actin staining in C3-treated PB T cells adherent to Fn. Cells
were either scrape loaded with BSA (50 mg/ml, left) or C3 (50 mg/ml, right)
then plated in modified Tyrodes buffer on glass coverslips that had been
coated with Fn (10 mg/ml). After 2 h, adherent cells were fixed in 2%
paraformaldehyde and stained with TRITC-phalloidin. Arrows in the right
panel represent clusters of filamentous actin in the extended pseudopods.1216 Rho-dependent Regulation of PB T Lymphocyte Cytoarchitecture and Activation
monocyte cell lines (20). The GTPase Rho has been impli-
cated in the regulation of actin filament assembly (10, 11).
Rho has been shown to be required for phosphatidylinosi-
tol 4-phosphate 5-kinase (PIP 5-kinase) function in mouse
fibroblasts (47), which is involved in the production of
phosphatidylinositol 4,5-bisphosphate (4,5-PIP2). It is in-
teresting to speculate that dysregulated 4,5-PIP2 levels
could be responsible for pseudopodial extension in Fn ad-
herent PB T cells that have been treated with C3. Actin fil-
ament nucleation and/or elongation may occur due to
steady state levels of 4,5-PIP2 being altered because a vari-
ety of cytoskeletal proteins involved in regulating cell mor-
phology have been shown to interact with, or be regulated
by, 4,5-PIP2 (for review see reference 48). Also, pseudopo-
dial extension in C3-treated PB T cells may be a manifesta-
tion of the apparent dichotomy in activity between Rho
and other GTPases such as Cdc42, as demonstrated in neu-
ronal cells (38).
ADP-Ribosylation of Rho Results in Inhibition of b1 Inte-
grin-mediated Costimulation of Proliferation. PB T cells can
be considered specialized sensory cells that seek out en-
counters with APC at nodal sites of antigen load, where
productive engagement results in proper immune re-
sponses. Molecular mechanisms regulating locomotory ma-
chinery and maintaining T cell polarization in migrating
cells inherently regulate T cell activation (8, 9, 49). Mor-
phological changes may be linked to T cell activation as cy-
toskeletal regulatory proteins such as gelsolin can modulate
phospholipase C (PLC) activity by competing for binding
to PLCs preferred substrate, 4,5-PIP2 (50). It is interesting
then that besides the morphological changes regulated by
GTPases of the Rho subfamily, a number of studies in
other cell types have demonstrated that these GTPases are
involved in the control of gene expression (51) and cell cy-
cle progression (52). Since ADP-ribosylation of Rho by C3
exoenzyme results in such profound morphological
changes in resting PB T cells, it was important to deter-
mine the effect C3 may have on their activation. Costimu-
lation of proliferation can be accomplished in PB T cells by
delivering signals through the TCR–CD3 complex in con-
junction with signals generated through costimulatory mol-
ecules such as integrins (53–59). Costimulation assays were
performed comparing cells that were scrape loaded with
BSA (50 mg/ml, as a control) to those that were scrape
loaded with C3 (50 mg/ml). To negate transitory effects
that inhibition of Rho activity may have had on T cell ad-
hesion to Fn not detected previously in the adhesion assays,
mAb specific to integrin subunits were used as the costimu-
latory signal instead of Fn. In Fig. 5 it is clear that ADP-
ribosylation of Rho has a dramatic effect on integrin-
dependent T cell costimulation. b1 (mAb 33B6) and a4b1
(mAb 19H8) integrin induced costimulation of T cell pro-
liferation was drastically inhibited, from 30,268 to 12,890
cpm and 20,185 to 9,336 cpm, respectively. Inhibition of
integrin-mediated costimulation of proliferation as mea-
sured by DNA synthesis could occur by a number of
mechanisms before entry into S phase of the cell cycle. In
T lymphocytes, mitogenic signaling induced by the pri-
mary T cell growth factor IL-2 leads to inactivation of
p27kip (60). Degradation of p27kip is required for G1 to S
transition (61, 62). Inactivation of Rho proteins by C3
transferase in Rat FRTL-5 cells inhibits the degradation of
p27kip (62). Also, inactivation of Rho proteins in a gastric
derived tumor cell line results in decreased cyclin A expres-
sion (29), which is required for transition from the G1 to S
phase of the cell cycle (63). Inhibiting DNA synthesis in
PB T cells by inactivation of Rho could occur by either of
these cell cycle–related processes. However, IL-2 is the
main cytokine produced that induces T cells to cycle into S
phase and synthesize DNA upon b1 integrin costimulation
(57). So, inactivation of Rho could be preventing induc-
tion of IL-2 synthesis at very early stages in PB T cell acti-
vation.
Inactivation of Rho Prevents Induction of IL-2 Production from
b1 Integrin/CD3- or CD28/CD3-costimulated PB T Cells,
but Not PMA- and Ionomycin-stimulated Cells. To test the
hypothesis that inhibition of T cell activation by ADP-
ribosylation of Rho was occurring at very early stages in T
cell activation, an assay for the measurement of intracellular
cytokine accumulation was used that can detect induction
of cytokine synthesis at the single cell level using FACSÒ
analysis (64) very early in T cell activation (28). The major-
ity of cells producing IL-2 when costimulated by the coim-
mobilization of FN and anti-CD3 mAb are of the CD41
phenotype (Woodside, D.G, D.E Long, and B.W. McIn-
tyre, manuscript submitted for publication). Hence, IL-2
measurements were obtained from CD41 cells that had
been scrape loaded with BSA or C3 (50 mg/ml), then
plated on bacteriological petri dishes that had been pre-
coated with costimulatory substrate (Fn, 10 mg/ml) or
mAbs (33B6 or 19H8, 10 mg/ml) in conjunction with anti-
CD3 mAb OKT3. Cells were activated for 6 h in the pres-
ence of 4 mM monensin, as this has been predetermined to
represent the time at which maximal intracellular IL-2 ac-
cumulation occurs (28). As Fig. 6 A demonstrates, ADP-
ribosylation of Rho by scrape loading of C3 exoenzyme
Figure 5. ADP-ribosylation of Rho inhibits b1 integrin-mediated co-
stimulation of proliferation in PB T lymphocytes. Purified PB T lympho-
cytes that were either scrape loaded with control buffer 1 BSA (50 mg/ml),
or with C3 transferase (50 mg/ml), were plated onto 96-well plates that
had been precoated with OKT3 alone, or OKT3 coimmobilized with
anti-b1 integrin mAb 33B6 or the anti-a4b1 integrin mAb 19H8. DNA
synthesis was determined as described in the experimental procedures.1217 Woodside et al.
inhibited the intracellular production of IL-2 induced by
costimulation through b1 integrins and CD3, by at least
81%. Unactivated cells, and cells that were plated on
OKT3 alone did not demonstrate any significant produc-
tion of IL-2 (data not shown). ADP-ribosylation of Rho
had very little effect on intracellular IL-2 accumulation
when PMA (10 mg/ml) and ionomycin (1 mM) were used
to activate T cells, as there was an average 4.4% increase in
IL-2 positive cells after C3 treatment (Fig. 6 B).
Since inactivation of Rho was specifically preventing in-
tegrin/CD3 costimulation of IL-2 production (but not
PMA/ionomycin costimulation), we tested another co-
stimulation scheme for the requirement of Rho activity.
PB T cells were plated on anti-CD28 and -CD3 mAbs in
complete media supplemented with 4 mM monensin. After
6 h activation, intracellular IL-2 was measured in the BSA
(50 mg/ml) control scrape-loaded cells and the C3 (50 mg/ml)
scrape-loaded cells. As demonstrated in Fig. 7, inactivation
of Rho by scrape loading C3 inhibits CD28/CD3 costim-
ulation of IL-2 production by at least 70% in CD41 T cells.
Downregulation of the ab-TCR Is Unaffected by Inactivation
of Rho in PB T Cells. Next we tested whether other re-
ceptor mediated events would be impaired upon the inacti-
vation of Rho with C3 exoenzyme. Ligation of the TCR
is associated with its internalization and thus downregula-
tion from the cell surface (65, 66). To test if this was af-
fected by C3 treatment, we took advantage of the ability to
measure intracellular accumulation of IL-2 while simulta-
neously monitoring cell surface expression of the ab-TCR
at the single cell level. Control (BSA scrape loaded) and test
cells (C3 scrape loaded) were treated under various activa-
tion conditions. Cells were then harvested and stained for
the ab-TCR, fixed in paraformaldehyde, solubilized with
saponin, and stained for intracellular IL-2. The results are
presented in Fig. 8. As expected, C3 treatment of periph-
eral blood lymphocytes inhibited CD28/CD3-dependent
costimulation of IL-2 production, by 43% (Fig. 8 A). The
percentage of cells positive for IL-2 in this experiment was
relatively low as compared with that reported in Fig. 7.
This is due to the absence of the Golgi disrupting agent
monensin. It was unclear what affect monensin would have
on normal intracellular trafficking and cell surface expres-
sion of the ab-TCR–CD3 complex, so it was not included
in these experiments. In part C of Fig. 8 the upper panels
contain ab-TCR expression histograms for BSA scrape-
loaded PB T cells (controls). The lower panels contain ab-
TCR expression histograms for C3 scrape-loaded cells. As
can be seen, even though there was .40% inhibition in the
percentage of cells positive for IL-2 after C3 treatment (Fig.
8 A), there was no change in these cells due to treatment
with C3 when cell surface expression of the ab-TCR was
examined. For example, when CD28 was cross-linked
alone, the ab-TCR mean fluorescence intensity was 11.3
and 11.6 for BSA and C3 scrape-loaded cells, respectively.
When the CD3 complex was cross-linked with immobi-
lized mAb OKT3, cell surface expression of the ab-TCR
decreased slightly, but again the mean fluorescence inten-
sity for BSA- or C3-treated cells was almost identical (10.5
and 10.4, respectively). When both CD28 and CD3 were
cross-linked at the same time with immobilized mAb, the
Figure 6. ADP-ribosylation of Rho protein inhibits early intracellular
IL-2 accumulation in PB T cells as determined by FACSÒ analysis at the
single cell level. (A) PB T cells were scrape loaded with control buffer 1
BSA (50 mg/ml) or with C3 transferase (50 mg/ml), and IL-2 was mea-
sured after 6 h of costimulation on plates coated with Fn, mAb 33B6
(anti-b1 integrin), or mAb 19H8 (anti-a4b1 integrin) coimmobilized
with anti-CD3 mAb OKT3. Because the CD41 population preferentially
coactivated due to integrin costimulation (data not shown), inhibition
values were calculated from the CD41 population only. The percent in-
hibition in IL-2 positive cells was calculated from one of three representa-
tive experiments. (B) Costimulation of IL-2 production was measured by
FACSÒ analysis for the entire population of PB T cells activated with
PMA (10 ng/ml) and ionomycin (1 mM). Cells were scrape loaded with
control buffer 1 BSA (50 mg/ml) or with C3 transferase (50 mg/ml) be-
fore activation and the IL-2 measured after 6 h of costimulation. Data
represents the averages 6 SEM from four separate donors. For parts A
and B, the percent inhibition in IL-2 positive cells was calculated as [1 2
(IL-21
C3 SCRAPE/IL-21
BSA SCRAPE)] 3 100, where IL-21
C3 SCRAPE 5 per-
centage of cells positive for intracellular IL-2 when scrape loaded with C3
and IL-21
BSA SCRAPE 5 percentage of cells positive for intracellular IL-2
when scrape loaded with BSA 1 control buffer.
Figure 7. Inactivation of Rho proteins inhibits CD28/CD3 induction
of IL-2 production. PB T cells scrape loaded with BSA (50 mg/ml) in
control buffer or C3 (50 mg/ml) were plated on bacteriological petri
dishes for 6 h in the presence of 4 mM monensin. CD4 and intracellular
IL-2 was stained as described in the experimental procedures and mea-
sured by FACSÒ analysis. At least 2 3 104 events were counted per test.
One representative experiment of four is shown. Left panel represents
IgG-PE control staining for intracellular IL-2. Middle and right panels
represent IL-2 production in BSA (50 mg/ml) scrape-loaded control cells
and C3 (50 mg/ml) scrape-loaded cells, respectively. Quadrate statistics
are shown in the upper right corner of each panel. Percent inhibition as
presented in the underlying chart was calculated as shown in Fig. 6 legend.1218 Rho-dependent Regulation of PB T Lymphocyte Cytoarchitecture and Activation
mean fluorescence intensity of the ab-TCR decreased log-
arithmically. The ab-TCR mean fluorescence intensity of
BSA scrape-loaded cells was 0.93, and the mean fluores-
cence intensity of C3 scrape-loaded cells was 0.74. Again,
there was little difference between the downregulation of
TCR expression on C3 treated or control cells due to
costimulatory signals. To summarize, receptor-mediated
TCR downregulation was unaffected by C3 treatment of
PB T cells even though C3 treatment did inhibit IL-2 pro-
duction by .40% in the same cell population.
Both b1 integrin and CD28 costimulation of PB T cell
IL-2 production require functional Rho. One possible ex-
planation of this is that Rho is regulating a common signal-
ing pathway used by both these costimulatory molecules.
Costimulatory signals such as those delivered by integrins
in PB T cells have been compared with adhesion depen-
dent signals required for anchorage dependent growth in fi-
broblast models, which are thought to provide substrate for
enzymes activated by growth factors (67). As previously
mentioned, Rho activity is required for PIP5-K–depen-
dent production of 4,5-PIP2 (47), which is the preferred
substrate for PLC. Cleavage of 4,5-PIP2 by PLC results in
the production of diacylglycerol (DAG), and inositol tri-
phosphate (IP3; for review see reference 68), both of which
have been implicated in PB T cell activation (for review
see reference 69). Expanding upon the anchorage-depen-
dent growth analogy in PB T cells treated with C3 exoen-
zyme, TCR signals activating PLC would be unproductive
with regard to cellular activation as inactive Rho may not
be sufficiently regulating levels of the PLC substrate 4,5-
PIP2. Since PMA activation of PKC (70) and ionomycin-
mediated Ca11 release are thought to mimic the effects of
the products of the lipase activity of PLC on 4,5-PIP2,
namely DAG and IP3, our finding that PMA and ionomy-
cin costimulation overcomes the C3 inhibitory effects sup-
port a role for Rho in the regulation of 4,5-PIP2 in PB T
cells. Consistent with this is the recent finding that transient
cytosolic Ca11 increases induced by Fc receptor cross-link-
ing in monocytes diminished after C3 microinjection (71).
Alternatively, as the common denominator between co-
stimulatory pathways involving CD28/CD3 and b1 inte-
grin/CD3 is cross-linking the CD3 complex, it is also pos-
sible that Rho activity is required for initiation or
propagation of TCR/CD3-specific signals. In this regard, it
has recently been demonstrated by Han et al. (72) that the
src tyrosine kinase lck regulates vav activity. Phosphory-
lated vav, which has a Dbl homology domain thought to
be responsible for guanine nucleotide exchange activity
(73, 74), has been implicated as a guanine nucleotide ex-
change factor for Rho family GTPases (72). If this is the
case in PB T cells, where the importance of lck activity is
well documented (for review see reference 75), activation
of Rho may be a key component of the TCR signal trans-
duction process.
That Rho may be a participant in costimulatory signals
or in TCR signals alludes to a third possibility. Rho could
be at a point of convergence or at the crossroads of TCR
and costimulatory molecule signaling mechanisms as Rho
activity could influence other GTPases important in PB T
cell activation. For example, phosphorylated p120 Ras
GTPase-activating protein (Ras-GAP) complexes with
phosphorylated p190 Rho-GAP (76–78). Dysregulation of
Rho activity could interfere with Ras-GAP/Rho-GAP in-
teractions, causing increased or accelerated Ras-GTPase
activity effectively blocking Ras-dependent signaling path-
ways.
Figure 8. Cell surface expression of the ab-
TCR and intracellular staining of IL-2. (A) Control
(BSA scrape loaded, 50 mg/ml) and test cells (C3
scrape loaded, 50 mg/ml) were activated with im-
mobilized anti-CD28 and anti-CD3 in the absence
of monensin, harvested, and intracellular staining
for IL-2 was performed after staining for the ab-
TCR as described in the Materials and Methods.
(B) Control staining for ab-TCR expression on
BSA scrape-loaded PB T cells. (C) Cells were
treated under the various conditions indicated then
stained for the ab-TCR. The upper panels of his-
tograms represent cells scrape loaded with BSA (50
mg/ml), and the lower panels of histograms repre-
sent C3 exoenzyme (50 mg/ml) scrape-loaded PB
T cells. The last column of histograms (treated with
anti-CD28 and anti-CD3 mAbs) were the same
population of cells that were stained for intracellular
IL-2 accumulation in A. This is representative of
two experiments performed with similar results.1219 Woodside et al.
This is the first demonstration that Rho activity is re-
quired in T lymphocyte activation and the maintenance of
normal T lymphocyte cytoarchitecture as inactivation of
Rho results in inhibition of IL-2 production and causes
pseudopodial extension in quiescent primary T lympho-
cytes. Determination of cytoskeletal regulatory elements,
signaling modules, and transcriptional factors affected when
Rho-inactivated T cells are costimulated will be an impor-
tant area of future study, as it may lead to novel strategies to
therapeutically regulate immune function by influencing T
lymphocyte activity on at least two different levels, migra-
tion and/or activation.
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